THIS WEBSITE USES COOKIES
We use cookies to personalise content, to provide social media features, and to analyse our traffic. By choosing 'allow all cookies', you consent to our cookies.
To find out more, read our privacy policy and cookie policy.
Adult glioblastoma
Paediatric high-grade glioma
EU initiative for understanding cancer
Magnetic resonance imaging
Standard of care
Immuno-oncology
Tumour treating fields
Maastricht University is the most international university in the Netherlands and distinguishes itself with its innovative education model, international character and multidisciplinary approach to research and education. UM and the University Hospital Maastricht work together under the umbrella organisation Maastricht University Medical Center+ which has three mutually reinforcing core tasks: patient care, research, education and training.
The Department of Precision Medicine is embedded in the Research School GROW and the Faculty of Health Medicine and Life Sciences at UM and consists of The D-lab, the M-Lab and the Clinical Trial Unit (CTU). The department has the ambition to be an internationally recognised leader in “Convergence Sciences”: the intersection of Medical Sciences, Biology and Technology. The D-Lab excels at applying artificial intelligence methods, such as explainable deep learning and handcrafted radiomics to medical imaging. The M-Lab is a basic science and translational research laboratory. The CTU manages phase 1 & 2 clinical trials, cohort studies and in silico trials.
What is UM’s main role?
Responsible for the imaging/radiomics analysis and the multiomics integrations as part of leading patient stratification through radio-multiomics data integration
Managing the imaging platform and the tools needed such as access to a Graphics Processing Units farm and a library of commercial and academic software
Which work packages is UM involved in?
See our dedicated page for more details on the GLIOMATCH work plan.
UM leads work package 4 and contributes to work packages 1, 7 and 8
Who represents UM?
GLIOMATCH Partners